Oncotype DX Breast Recurrence Score is a prognostic and predictive assay of 21 genes. initially designed for therapy planning in patients with hormone receptor (HR)-positive. human epidermal growth factor receptor 2 (HER2)-negative. lymph node-negative or lymph node-positive (maximum 3 nodes involved). https://medicalwarehouses.shop/product-category/bariatric-commodes/